Member Info for stt1

Citizen
"that's easily answered sttf, you just have to read to the third line:"

My post was on "Current cash balance as of 31st May 2022" not cash as of 5 months ago, 31st Dec.
As I said in my post, they published the 'current cash balance' as of 31st May when they reported last year, so why not this?

Elrico,
If their cash was increasing then I'm sure they would have reported it.

It raises the question why they have omitted crucial information. Possible placing..

In their fy2020 Annual Report they stated:

" As at 31 December 2020 cash and cash equivalents were £19.2m. Cash as of end May was £15.1m, reflecting the expected release of customer prepayments in H1 2021, which should build back strongly by year end as we close contracts for execution in 2022"

As you can see from the fy results the cash did not build back strongly by year end. They ended fy2021, Dec with £15.7m.

So it's quite likely the cash has reduced further since Dec 31st.

How much cash do they currently have? They don't mention the current cash balance, why not?

The results raised more questions than it answered. Vague about spin off delays when the market was right not long ago.
Didn't they say the DiM spin off will be post Polb lock in period ending? That says to me that because the Polb lock in period ending was a complete mess in that many PIs didn't receive their shares (and many still waiting) that the BoD thought that any spin off is likely to be a flop...
How many months/years is it likely to be before the 'right conditions' exist again??? Given the significant value in OO was DiM and the other spin offs then why buy OO now???

As I previously mentioned there is a questionable corporate structure and the results doesn't alleviate my concern.
The results and webcast also point to kitchen sinking by Mo. Are there any skeletons in the cupboard???

Easy question. How much cash do they currently have? They had no problem publishing the current cash balance (as of 31st May 2021) last year when they published the fy2020 results, so why not this year????

TLY have revamped their website.

Their services now listed as:

Urgent care
Elective care and outpatient services
First Contact Practitioner
Prison health
Corporate wellbeing

https://www.totallyplc.com/

Elective Care(Insourcing) and separately listed 'Prison Health'/'Corporate Wellbeing'

TLY's strategy was to build a diversified business to become a leading Out of Hospital (OOH) provider.

They have only recently reached that goal. They clearly don't need to raise cash, they paying dividends, have increasing recurring revenues and are winning new contracts.

Now the foundation has been set and investors are at last seeing the huge potential, I agree it seems to me the wrong to be selling out.

The govn focus is now to reduce the backlog of operations, reduce A&E/GP waiting times, planned care for OOH.

There are also changes to come with NHS. As I've posted before, these were already expected and TLY are well positioned for them.

As far as I'm concerned, foundation set and lots to look forward to.

Totally sees profits beating market forecasts as Covid drives rise in demand

The company won new contracts worth £59mln and contract extensions worth £72mln in the 12-month period to end-March

https://www.proactiveinvestors.co.uk/companies/news/980395/totally-sees-profits-beating-market-forecasts-as-covid-drives-rise-in-demand-980395.html

EBITDA expected to be substantially ahead of consensus

- Year-end cash significantly higher than forecast

- An exceptionally strong year

– Pioneer integrating well

- Growth opportunities and market position not reflected in share price

" Growth opportunities and market position not reflected in share price – This is an upbeat trading update and we remain confident that further progress will be made in FY23 and FY24. We look forward to the results in July when we will have an opportunity to revisit our forecasts. Fair value remains at 75p "

https://www.allenbycapital.com/our-research/?fwp_research_client=440

It's not unusual for PIs to appear on the holding register of micro companies.

The thing to look out for is if now posters (mates) appear to pull the wool over reader's eyes to 'pump' and 'dump' these. watch for any manipulation of the sp.

Read my posts over past 2 years, the company/sector newsflow was exactly as I predicted. These were pumped/dumped.

The company has a history of missed expectations/missed opportunities.

Read all bull/bear posts.

NHS England - waiting lists at record high.

Number of people on NHS waiting lists in England at record high

"Figures show 6.2m people waiting for routine hospital treatment, with A&E and ambulance waits also soaring"

https://www.theguardian.com/society/2022/apr/14/number-of-people-on-nhs-waiting-lists-in-england-at-record-high

Those are for NHS England only.

TLY, through it's insourcing division provides it's services to all 4 UK nations and since June last year, the Republic of Ireland.

Their other divisions, within their diversified business model, include Urgent Care, Planned Care, Wellbeing services for Company staff.

Growing recurring revenues of £120m+++, cash £11m, pays dividends.
Mcap £75m

Last year the fy TU was on 13th April, so hopefully we should get fy TU next week.

Growing recurring revenues of £120m+++
Cash in bank approx £11m.

Paying dividends.

Last 5 years:
period revenue, cash, adj Ebitda
2017 £21.3m, £11.3m, £5.6m
2018 £42m, £10.2m, £0.2m
2019 £78m, £7.5m, £1.1m
2020 £105m, £8.9m, £4m
2021 £113m, £14.8m, £5m
*2022E £122.9m, £11.0m, £5.5m
*2023E £140m, £13m, £8.3m

*Est is from Allenby, the company broker in March 2022.

sp 38p
Mcap £71m

"Insourcing is a system whereby hospitals subcontract medical services and procedures to Totally Healthcare who then utilise hospital premises and equipment for service delivery.

The insourcing model is cost-effective model and reduces the pressure caused by long waiting lists, while providing patients quicker access to care and a high-quality service.

This may be a small division in terms of Group revenue, but it is high margin and growing fast with Totally expecting significant growth from this segment as the government seeks to clear the vast NHS backlog."

https://aiminvestor.co.uk/open-positions/buy-totally-tly/

Tricky,
"stt1 states that TLY are integral to clearing NHS waiting lists."

It was the title of the article!!!. lol.
You really should read posts and do some research, it'll help you stop repeatedly embarrasing yourself. lol

Totally integral to clearing record NHS backlog
https://aiminvestor.co.uk/open-positions/buy-totally-tly/

TLY, through it's insourcing division provides it's services all 4 UK nations and from this year, Republic of Ireland. That's a huge footprint.

"Totally Healthcare – provider of insourcing to reduce hospital waiting lists"

https://www.totallyplc.com/our-businesses/totally-healthcare/

thanks Thordon

Good summary of TLY and it's business model and prospects.

Totally integral to clearing record NHS backlog

"The Government and NHS England have set the ambition of eliminating all waits of more than a year by March 2025, a target that will be funded through a Health & Social Care package worth more than £36bn over the next three years.

A company that is integral to the government coming anywhere near its NHS backlog targets is Totally (TLY)."

https://aiminvestor.co.uk/open-positions/buy-totally-tly/

Qwerty
"Anyway back to bouncing around for the next six months..."

agree. the vicious circle, US following UK following US until news.

The company (blnx/rthm/tap/trmr) has a history of buy backs, court cases, placings and massive director awards and then repeat. lol

There you go, nothing new then.
- months and still no new contracts
- months and still no DiM spin off date..postponed since last year
- still no DiM contradts.
- still please don't sell your Polb shares when lock in period ends - announce some contract news before lock in period ends and PIs won't be tempted to sell.
- still 95%/£50m booked for 2022, no new contracts.

If they don't publish audited results within 6 months, ie end June, then shares will be suspended.

A lot of talk, a lot of jam tomorrow.
Actions speak louder than words.

Chesire,
"Good to see what a difference some communication from the board can seemingly make"

They have been giving presentations throughout so comms is nothing new. is it?

Here's what they were saying a year ago. Whatever happened to the £60m covid contracts which were close to being signed???
Their communication didn't stop the sp from crashing because PIs soon realised that they were missing expectations.

They have a history over promising, missing expectation, no contracts for DiM, no spin off for DiM.

£100m mcap for jam tomorrow??

I see more gullible PIs are getting drawn in as they have been several times before only to be left disappointed.

Don't take my word for it, listen to last year's presentation yourself and then look at the company/sector newsflow and sp downward trend which followed.

Listen to their presentation last year and yoHere was their presentation last year.

Here is CF's presentation from a year ago where CF said he was very close to signing £60m of covid contracts, most would be £10m+++.

Whatever happened to that 'very close to signing'???
Yet what is the total expected revenue for fy2021? £40m-£50m...lol

Don't take my word for it, listen to his presentation yourself..
This was trader_3's post from last year.

Cathal stated on last year's presentation:-

Cathal Friel - £60 million plus for new Covid CHIM contracts?

~9 min 50 sec

"In the very close future we'll be signing quite a few Covid 19 antivirals, quite a few Covid vaccination trials and as soon as they're signed you'll see the announcements and most of those trials will be north of £10 million.these are premium products and this is the only place in the world you can get them done.

https://www.youtube.com/watch?v=qIQpEiS1ZmE&ab_channel=Proactive

Best to trade and not get caught out again by the baseless ramping..

"CF focused on spin-outs, things will I believe move forward."

He was focusing on spin-offs last year. The Polb spin off with it's 9 month lock in hasn't done well, esp as the lock in period ends next month, so there's a potential sell off by PIs as soon as the lock in ends.

Every presentation it's things are different but they haven't been. Look at the previous presentations and rns, a spike followed by selling.

Best to trade and not get caught out again.

For those who think the presentation is a turning point.
To back up my stance re the company having a history of over promising, missing expectations. Also my stance on the £75m being jam tomorrow..

This was CF's corresponding presentation from a year ago.

Note the 'in very near future' comment as opposed to current £75m pipeline.
Whatever happened to those £60m contracts to be signed in 'the very near future'??

Have a listen yourself.

Trader_3 - 22 Mar 2021 - 10:35:02 - 13422 of 20224
Cathal Friel - £60 million plus for new Covid CHIM contracts?

Cathal stated on his recent presentation:-

~9 min 50 sec

"In the very close future we'll be signing quite a few Covid 19 antivirals, quite a few Covid vaccination trials and as soon as they're signed you'll see the announcements and most of those trials will be north of £10 million.these are premium products and this is the only place in the world you can get them done.?

https://www.youtube.com/watch?v=qIQpEiS1ZmE&ab_channel=Proactive

So that should have been £60 million plus of contracts ˜in the very close future", in addition to everything else. Yet their total fy revenue for fy 2021 is around £40m-£50m.

£75m pipeline is jam tomorrow until contracts are actually signed. It means nothing. The company does have a history of overpromising, under delivering and missing expectations.

Still no contracts for DiM, still no DiM spin off date. It was originally planned for last year then early this year.

In terms of sp movement, have a look at the sp spikes following previous presentations and rns. The sp fell back following the spike.

I said that 4x revenues was too expensive and the mcap should be around £100m. The mcap did fall back to £100m, as expected

Investor meet presentation following Pioneer healthcare acquisition..

https://presentations.investormeetcompany.com/investor-meet-company/TOTALLY-PLC-Investor-Presentation

A strategically important and earnings enhancing acquisition

"– Extremely well positioned to support the NHS in reducing patient waiting lists - The insourcing and outsourcing services provided by Pioneer and Totally are positioned to support the NHS in reducing patient waiting lists for pre-planned treatment which at 6.07m people, has reached record levels. To put this number into context, if one person was treated every minute of every day (24 hours a day) it would still take over 11 years to reduce the list to zero."

"High demand but a limited number of qualified providers - Organisations qualified and on the respective key NHS frameworks to provide these services are limited, thus providing a significant barrier to entry. For outsourced services there are 37 such providers and for insourcing services there are just 18 (two of these belonging to Totally).
Pioneer is also one of only three providers known to provide both insourcing and outsourcing services."

"Immediately earnings enhancing – The acquisition will be immediately enhancing but will have minimal impact on Group results for FY22 (apart from the cash outflow from the initial cash consideration) but will be consolidated for 12 months of FY23 for which year we are raising adjusted EPS forecasts by 30% to 3.0p (yoy growth of 65%). For FY24 we are forecasting yoy EPS growth of 39% to 4.1p (26% above our previous forecast). At September 2021, Totally had cash of £18.3m and the Group continues to generate cash.
Therefore, cash balances are still expected to be more than adequate to fund working capital, even after funding the acquisition. To reflect the enhanced earnings and strong strategic positioning of the Group we are increasing fair value from 65p to 75p."

https://www.allenbycapital.com/our-research/?fwp_research_client=440